GlassScriptPhysician profile
Punam Trivede
NPI 1790258473
$946.86
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $97.48 · 2023: $682 · 2024: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $121.60 | 2022-2023 | Hetlioz, Fanapt |
| Teva Pharmaceuticals USA, INC. | $118.49 | 2022-2023 | Austedo |
| Dexcom, INC. | $110.92 | 2023 | Dexcom G7 Gss (161) |
| Janssen Pharmaceuticals, INC | $107.70 | 2023-2024 | Spravato, Invega Sustenna |
| Bayer Healthcare Pharmaceuticals INC. | $90.25 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $85.84 | 2023-2024 | Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $83.48 | 2023-2024 | Ingrezza, Ongentys |
| Lilly USA, LLC | $33.40 | 2023 | Mounjaro |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $29.69 | 2024 | Caplyta |
| Biogen, INC. | $26.99 | 2023 | |
| Xeris Pharmaceuticals, INC. | $23.51 | 2024 | Gvoke Hypopen |
| Abbott Laboratories | $21.97 | 2024 | Freestyle Libre 3 |
| Indivior INC. | $21.94 | 2023 | Sublocade |
| Exact Sciences Corporation | $21.17 | 2023 | Cologuard Collection Kit |
| Amgen INC. | $20.02 | 2023 | Otezla, Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $16.92 | 2023 | Jornay Pm |
| Hologic Sales and Service, LLC | $12.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Punam Trivede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.